Showing results (41-50 of 53) with videos related to

Sort By:
Pageof 6
Frontiers in Immunology|August 18, 2025
Induction immunochemotherapy followed by definitive chemoradiotherapy and consolidation immunotherapy for unresectable stage III non-small cell lung cancer: a multi-institutional retrospective cohort studyZhixue Fu, Xin Dong, Jiawen Sun, et al.
Frontiers in Oncology|March 14, 2022
Effects of Enteral Nutrition on Patients With Oesophageal Carcinoma Treated With Concurrent Chemoradiotherapy: A Prospective, Multicentre, Randomised, Controlled StudyJiahua Lyu, Anhui Shi, Tao Li, et al.
The Lancet. Respiratory Medicine|August 15, 2024
High-dose hyperfractionated simultaneous integrated boost radiotherapy versus standard-dose radiotherapy for limited-stage small-cell lung cancer in China: a multicentre, open-label, randomised, phase 3 trialJiayi Yu, Leilei Jiang, Lina Zhao, et al.
British Journal of Cancer|October 20, 2023
Nimotuzumab plus concurrent chemo-radiotherapy in unresectable locally advanced oesophageal squamous cell carcinoma (ESCC): interim analysis from a Phase 3 clinical trialXue Meng, Anping Zheng, Jun Wang, et al.
International Journal of Radiation Oncology, Biology, Physics|November 19, 2022
High-Dose Versus Standard-Dose Intensity-Modulated Radiotherapy With Concurrent Paclitaxel Plus Carboplatin for Patients With Thoracic Esophageal Squamous Cell Carcinoma: A Randomized, Multicenter, Open-Label, Phase 3 Superiority TrialJing You, Shuchai Zhu, Jiancheng Li, et al.
JTO Clinical and Research Reports|July 30, 2026
Durvalumab Consolidation Treatment Following Concurrent Chemoradiotherapy in Limited-Stage SCLC: ADRIATIC China Subgroup AnalysisLixia Ma, Qiming Wang, Jian Fang, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 1, 2026
Durvalumab Consolidation in Limited-Stage SCLC: Outcomes by Prior Concurrent Chemoradiotherapy and Prophylactic Cranial Irradiation in the Phase 3 ADRIATIC TrialSuresh Senan, Byoung Chul Cho, Konstantin K Laktionov, et al.
BMC Cancer|April 8, 2020
Efficacy and safety of concurrent chemoradiotherapy in ECOG 2 patients with locally advanced non-small-cell lung cancer: a subgroup analysis of a randomized phase III trialNan Bi, Lipin Liu, Jun Liang, et al.
The American Journal of Gastroenterology|March 27, 2023
Radiotherapy Improves Survival of Patients With Lymphovascular Invasion in pT1b Esophageal Squamous Cell Cancer After Endoscopic Submucosal DissectionXu Yang, Lina Zhao, Anhui Shi, et al.
Targeted Oncology|May 3, 2026
Real-World Treatment Patterns and Clinical Outcomes Among Chinese Patients with Stage III NSCLC: The MOOREA StudyLigang Xing, Jinming Yu, Xiangjiao Meng, et al.
Pageof 6